Below are some of the most frequently asked questions about OUR COMPANY. If you don't find what you're looking for here, please contact us directly.
BioSpecifics is traded on the NASDAQ Global Market under the symbol BSTC.
BioSpecifics was incorporated in 1990 in the state of Delaware.
BioSpecifics corporate headquarters are currently located at Delaware Corporate Center II, 2 Righter Parkway, Suite 200, Wilmington, DE 19803.
BioSpecifics’ fiscal year ends December 31.
EisnerAmper LLP is BioSpecifics’ independent audit firm.
Please sign up for email alerts in the Investors section of BioSpecifics’ website.
These documents may be obtained on BioSpecifics’ website under the Investors section. SEC filings may also be obtained from the SEC website, www.sec.gov.
Sarah McCabe Stern Investor Relations sarah.mccabe@sternir.com